DIAGNOS (CVE:ADK) Director Robert Dunn Purchases 200,000 Shares of Stock

DIAGNOS Inc. (CVE:ADK) Director Robert Dunn bought 200,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 29th. The shares were bought at an average cost of C$0.30 per share, for a total transaction of C$60,000.00. Following the transaction, the director directly owned 2,117,778 shares of the company’s stock, valued at C$635,333.40. This trade represents a 10.43% increase in their position.

DIAGNOS Stock Performance

CVE:ADK traded up C$0.01 during trading hours on Friday, hitting C$0.28. 35,149 shares of the company traded hands, compared to its average volume of 210,613. The company has a current ratio of 1.49, a quick ratio of 0.68 and a debt-to-equity ratio of 204.05. DIAGNOS Inc. has a twelve month low of C$0.17 and a twelve month high of C$0.41. The firm has a 50-day moving average of C$0.23 and a 200 day moving average of C$0.26. The stock has a market capitalization of C$33.72 million, a price-to-earnings ratio of -7.00 and a beta of -0.12.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.